Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice

Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice

To evaluate the prescribing habits of glaucoma specialists and of general ophthalmologists, and reveal the conformance with European Glaucoma Society (EGS) guidelines in the medical treatment of primary open-angle glaucoma (POAG) and ocular hypertension (OHT). Patients receiving medical treatment fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of ocular pharmacology and therapeutics 2020-12, Vol.36 (10), p.747-753
Hauptverfasser: Alagöz, Neşe, Tellioglu, Adem, Bektasoglu, Damla Leman, Yasar, Tekin, Basgil Pasaoglu, Isıl, Altan, Ayse Cigdem, Solmaz, Banu, Basarır, Berna
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 753
container_issue 10
container_start_page 747
container_title Journal of ocular pharmacology and therapeutics
container_volume 36
creator Alagöz, Neşe
Tellioglu, Adem
Bektasoglu, Damla Leman
Yasar, Tekin
Basgil Pasaoglu, Isıl
Altan, Ayse Cigdem
Solmaz, Banu
Basarır, Berna
description To evaluate the prescribing habits of glaucoma specialists and of general ophthalmologists, and reveal the conformance with European Glaucoma Society (EGS) guidelines in the medical treatment of primary open-angle glaucoma (POAG) and ocular hypertension (OHT). Patients receiving medical treatment for POAG/OHT in the glaucoma clinic comprised the "naive group." Patients having a diagnosis and a treatment for POAG/OHT initiated in another center before presentation comprised the second group and were named as "treatment initiated elsewhere" (TIEW). All patients were retrospectively evaluated from the patients' charts. The outcome measures included the percentage of eyes treated with monotherapy, the molecule groups preferred, and the change in prescription trends over the years in both groups. Seventy-two subjects were included in the naive group and 135 subjects in TIEW group. The rate of monotherapy was 76% and 36% in both groups, respectively. The molecule number was significantly higher in the TIEW group compared with naive group (1.98 ± 0.89 vs. 1.28 ± 0.56,  
doi_str_mv 10.1089/jop.2020.0032
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1089_jop_2020_0032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>33326338</sourcerecordid><originalsourceid>FETCH-LOGICAL-c216t-87edfaf7cbb2ddad7cbc4952c9e6e9ae19dc40587bfab57dd6e77f9b8ff336c33</originalsourceid><addsrcrecordid>eNo9kNFq2zAUhsVYWdpsl7st5wWcyFZt2VcjpFlayEjZOnZpjqWjRsGWjCwz8jx90Tpk69X5Lz4-OB9jX1O-SHlZLY--X2Q84wvORfaBXad5LhMpRfZx2rzkiSxKMWM3w3DkPBW8SD-xmRAiK4Qor9nrvYc_BGvvjA8d_LXxAJsx-J7QwbbFUfkO4ZdXluIJtqPV1FpHA1gH8UDwg7RV2MJzIIwduQjewFOwHYYT7Htyycq9tPSuWu7V2GKAh1NPIZIbrHff4B4jggm-A4SfhG2ys4YmDapoFX1mVwbbgb78u3P2-_vmef2Q7Pbbx_Vql6gsLWJSStIGjVRNk2mNehrqrsozVVFBFVJaaXXH81I2Bptcal2QlKZqSmOEKJQQc5ZcvCr4YQhk6v7ySJ3y-hy7nmLX59j1OfbE3174fmw60u_0_7riDRsXfoo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice</title><source>Alma/SFX Local Collection</source><creator>Alagöz, Neşe ; Tellioglu, Adem ; Bektasoglu, Damla Leman ; Yasar, Tekin ; Basgil Pasaoglu, Isıl ; Altan, Ayse Cigdem ; Solmaz, Banu ; Basarır, Berna</creator><creatorcontrib>Alagöz, Neşe ; Tellioglu, Adem ; Bektasoglu, Damla Leman ; Yasar, Tekin ; Basgil Pasaoglu, Isıl ; Altan, Ayse Cigdem ; Solmaz, Banu ; Basarır, Berna</creatorcontrib><description>To evaluate the prescribing habits of glaucoma specialists and of general ophthalmologists, and reveal the conformance with European Glaucoma Society (EGS) guidelines in the medical treatment of primary open-angle glaucoma (POAG) and ocular hypertension (OHT). Patients receiving medical treatment for POAG/OHT in the glaucoma clinic comprised the "naive group." Patients having a diagnosis and a treatment for POAG/OHT initiated in another center before presentation comprised the second group and were named as "treatment initiated elsewhere" (TIEW). All patients were retrospectively evaluated from the patients' charts. The outcome measures included the percentage of eyes treated with monotherapy, the molecule groups preferred, and the change in prescription trends over the years in both groups. Seventy-two subjects were included in the naive group and 135 subjects in TIEW group. The rate of monotherapy was 76% and 36% in both groups, respectively. The molecule number was significantly higher in the TIEW group compared with naive group (1.98 ± 0.89 vs. 1.28 ± 0.56,  &lt; 0.001). Until 2003, beta blockers, and in the 2003-2008 period, prostaglandin analogs (PGAs) were the mostly prescribed drugs in glaucoma clinic. From 2009, the rate of PGAs declined, with PGAs being replaced by combination drugs and alfa-2 agonists. Overtreatment rate was high among patients receiving a diagnosis and a treatment by general ophthalmologists, whereas glaucoma specialists were found to conform with EGS guidelines. A shift toward polypharmacy was observed from 2000 to 2017. The common guidelines to evaluate and treat glaucoma need to be adopted by the general ophthalmologists in their real-life practice.</description><identifier>ISSN: 1080-7683</identifier><identifier>EISSN: 1557-7732</identifier><identifier>DOI: 10.1089/jop.2020.0032</identifier><identifier>PMID: 33326338</identifier><language>eng</language><publisher>United States</publisher><ispartof>Journal of ocular pharmacology and therapeutics, 2020-12, Vol.36 (10), p.747-753</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c216t-87edfaf7cbb2ddad7cbc4952c9e6e9ae19dc40587bfab57dd6e77f9b8ff336c33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33326338$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alagöz, Neşe</creatorcontrib><creatorcontrib>Tellioglu, Adem</creatorcontrib><creatorcontrib>Bektasoglu, Damla Leman</creatorcontrib><creatorcontrib>Yasar, Tekin</creatorcontrib><creatorcontrib>Basgil Pasaoglu, Isıl</creatorcontrib><creatorcontrib>Altan, Ayse Cigdem</creatorcontrib><creatorcontrib>Solmaz, Banu</creatorcontrib><creatorcontrib>Basarır, Berna</creatorcontrib><title>Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice</title><title>Journal of ocular pharmacology and therapeutics</title><addtitle>J Ocul Pharmacol Ther</addtitle><description>To evaluate the prescribing habits of glaucoma specialists and of general ophthalmologists, and reveal the conformance with European Glaucoma Society (EGS) guidelines in the medical treatment of primary open-angle glaucoma (POAG) and ocular hypertension (OHT). Patients receiving medical treatment for POAG/OHT in the glaucoma clinic comprised the "naive group." Patients having a diagnosis and a treatment for POAG/OHT initiated in another center before presentation comprised the second group and were named as "treatment initiated elsewhere" (TIEW). All patients were retrospectively evaluated from the patients' charts. The outcome measures included the percentage of eyes treated with monotherapy, the molecule groups preferred, and the change in prescription trends over the years in both groups. Seventy-two subjects were included in the naive group and 135 subjects in TIEW group. The rate of monotherapy was 76% and 36% in both groups, respectively. The molecule number was significantly higher in the TIEW group compared with naive group (1.98 ± 0.89 vs. 1.28 ± 0.56,  &lt; 0.001). Until 2003, beta blockers, and in the 2003-2008 period, prostaglandin analogs (PGAs) were the mostly prescribed drugs in glaucoma clinic. From 2009, the rate of PGAs declined, with PGAs being replaced by combination drugs and alfa-2 agonists. Overtreatment rate was high among patients receiving a diagnosis and a treatment by general ophthalmologists, whereas glaucoma specialists were found to conform with EGS guidelines. A shift toward polypharmacy was observed from 2000 to 2017. The common guidelines to evaluate and treat glaucoma need to be adopted by the general ophthalmologists in their real-life practice.</description><issn>1080-7683</issn><issn>1557-7732</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNo9kNFq2zAUhsVYWdpsl7st5wWcyFZt2VcjpFlayEjZOnZpjqWjRsGWjCwz8jx90Tpk69X5Lz4-OB9jX1O-SHlZLY--X2Q84wvORfaBXad5LhMpRfZx2rzkiSxKMWM3w3DkPBW8SD-xmRAiK4Qor9nrvYc_BGvvjA8d_LXxAJsx-J7QwbbFUfkO4ZdXluIJtqPV1FpHA1gH8UDwg7RV2MJzIIwduQjewFOwHYYT7Htyycq9tPSuWu7V2GKAh1NPIZIbrHff4B4jggm-A4SfhG2ys4YmDapoFX1mVwbbgb78u3P2-_vmef2Q7Pbbx_Vql6gsLWJSStIGjVRNk2mNehrqrsozVVFBFVJaaXXH81I2Bptcal2QlKZqSmOEKJQQc5ZcvCr4YQhk6v7ySJ3y-hy7nmLX59j1OfbE3174fmw60u_0_7riDRsXfoo</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Alagöz, Neşe</creator><creator>Tellioglu, Adem</creator><creator>Bektasoglu, Damla Leman</creator><creator>Yasar, Tekin</creator><creator>Basgil Pasaoglu, Isıl</creator><creator>Altan, Ayse Cigdem</creator><creator>Solmaz, Banu</creator><creator>Basarır, Berna</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202012</creationdate><title>Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice</title><author>Alagöz, Neşe ; Tellioglu, Adem ; Bektasoglu, Damla Leman ; Yasar, Tekin ; Basgil Pasaoglu, Isıl ; Altan, Ayse Cigdem ; Solmaz, Banu ; Basarır, Berna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c216t-87edfaf7cbb2ddad7cbc4952c9e6e9ae19dc40587bfab57dd6e77f9b8ff336c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alagöz, Neşe</creatorcontrib><creatorcontrib>Tellioglu, Adem</creatorcontrib><creatorcontrib>Bektasoglu, Damla Leman</creatorcontrib><creatorcontrib>Yasar, Tekin</creatorcontrib><creatorcontrib>Basgil Pasaoglu, Isıl</creatorcontrib><creatorcontrib>Altan, Ayse Cigdem</creatorcontrib><creatorcontrib>Solmaz, Banu</creatorcontrib><creatorcontrib>Basarır, Berna</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of ocular pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alagöz, Neşe</au><au>Tellioglu, Adem</au><au>Bektasoglu, Damla Leman</au><au>Yasar, Tekin</au><au>Basgil Pasaoglu, Isıl</au><au>Altan, Ayse Cigdem</au><au>Solmaz, Banu</au><au>Basarır, Berna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice</atitle><jtitle>Journal of ocular pharmacology and therapeutics</jtitle><addtitle>J Ocul Pharmacol Ther</addtitle><date>2020-12</date><risdate>2020</risdate><volume>36</volume><issue>10</issue><spage>747</spage><epage>753</epage><pages>747-753</pages><issn>1080-7683</issn><eissn>1557-7732</eissn><abstract>To evaluate the prescribing habits of glaucoma specialists and of general ophthalmologists, and reveal the conformance with European Glaucoma Society (EGS) guidelines in the medical treatment of primary open-angle glaucoma (POAG) and ocular hypertension (OHT). Patients receiving medical treatment for POAG/OHT in the glaucoma clinic comprised the "naive group." Patients having a diagnosis and a treatment for POAG/OHT initiated in another center before presentation comprised the second group and were named as "treatment initiated elsewhere" (TIEW). All patients were retrospectively evaluated from the patients' charts. The outcome measures included the percentage of eyes treated with monotherapy, the molecule groups preferred, and the change in prescription trends over the years in both groups. Seventy-two subjects were included in the naive group and 135 subjects in TIEW group. The rate of monotherapy was 76% and 36% in both groups, respectively. The molecule number was significantly higher in the TIEW group compared with naive group (1.98 ± 0.89 vs. 1.28 ± 0.56,  &lt; 0.001). Until 2003, beta blockers, and in the 2003-2008 period, prostaglandin analogs (PGAs) were the mostly prescribed drugs in glaucoma clinic. From 2009, the rate of PGAs declined, with PGAs being replaced by combination drugs and alfa-2 agonists. Overtreatment rate was high among patients receiving a diagnosis and a treatment by general ophthalmologists, whereas glaucoma specialists were found to conform with EGS guidelines. A shift toward polypharmacy was observed from 2000 to 2017. The common guidelines to evaluate and treat glaucoma need to be adopted by the general ophthalmologists in their real-life practice.</abstract><cop>United States</cop><pmid>33326338</pmid><doi>10.1089/jop.2020.0032</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1080-7683
ispartof Journal of ocular pharmacology and therapeutics, 2020-12, Vol.36 (10), p.747-753
issn 1080-7683
1557-7732
language eng
recordid cdi_crossref_primary_10_1089_jop_2020_0032
source Alma/SFX Local Collection
title Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T16%3A14%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Do%20We%20Conform%20with%20European%20Glaucoma%20Society%20Guidelines%20in%20the%20Medical%20Treatment%20of%20Primary%20Open-Angle%20Glaucoma/Ocular%20Hypertension?%20Data%20from%20a%20Real-Life%20Practice&rft.jtitle=Journal%20of%20ocular%20pharmacology%20and%20therapeutics&rft.au=Alag%C3%B6z,%20Ne%C5%9Fe&rft.date=2020-12&rft.volume=36&rft.issue=10&rft.spage=747&rft.epage=753&rft.pages=747-753&rft.issn=1080-7683&rft.eissn=1557-7732&rft_id=info:doi/10.1089/jop.2020.0032&rft_dat=%3Cpubmed_cross%3E33326338%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33326338&rfr_iscdi=true